Related Experiment Video
Updated: Jan 19, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Immune-Mediated Therapies in Lymphoma
Sheryl G Forbes1, Haleigh E Mistry1
1M.D. Anderson Cancer Center, Houston, TX.
Novel lymphoma therapies offer improved outcomes but carry risks of immune-mediated adverse events. Early identification and multidisciplinary management are crucial for patient safety and effective treatment.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Lymphoma encompasses various lymphoid malignancies.
- Risk factors for lymphoma development are diverse.
- Emerging therapies aim to improve patient prognoses.
Purpose of the Study:
- To review lymphoma types and risk factors.
- To evaluate novel immune-mediated therapies for lymphoma.
- To assess associated side effects and toxicity management.
Main Methods:
- Literature review of published studies.
- Analysis of national statistics.
- Examination of relevant websites.
Main Results:
- Novel biologic agents show promise for enhanced lymphoma treatment outcomes.
- These advanced therapies can lead to unique and severe adverse events.
- Immune-mediated toxicities are a significant concern.
Conclusions:
- Management of immune-mediated adverse events necessitates a collaborative, multidisciplinary strategy.
- Prompt recognition of these toxicities is essential.
- Educating healthcare providers and nurses on managing lymphoma treatment toxicities is imperative.
Related Concept Videos
14:04Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Cell-mediated Immune Responses
04:23Determining the Role of Neutrophil-Like Cells in Lymphoma Cell Sensitivity to a Test Drug
02:55Quantification of Immune Mediator Levels in Human Mucosal Lining Fluid
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
10:52Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

